Fukushima Medical University is a public university, located in the city of Fukushima, Japan.

During the past decade, Fukushima Medical University Hospital conducted 67 clinical trials. In the 10-year time frame, 67 clinical trials started and 24 clinical trials were completed, i.e. on average, 35.8% percent of trials that started reached the finish line to date. In the past 5 years, 42 clinical trials started and 20 clinical trials were completed. i.e. 47.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fukushima Medical University Hospital" #1 sponsor was "Hoffmann-La Roche" with 14 trials, followed by "Pfizer" with 7 trials sponsored, "Bayer" with 6 trials sponsored, "Fukushima Medical University" with 6 trials sponsored and "Janssen Pharmaceutical K.K." with 6 trials sponsored. Other sponsors include 46 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fukushima Medical University Hospital" #1 collaborator was "Human Genome Center, Institute of Medical Science, University of Tokyo" with 4 trials as a collaborator, "Chugai Pharmaceutical" with 3 trials as a collaborator, "Regeneron Pharmaceuticals" with 3 trials as a collaborator, "Japan Lung Cancer Society" with 2 trials as a collaborator and "Niigata University Medical & Dental Hospital" with 2 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Fukushima Medical University Hospital" are "Gastric Cancer" (4 trials), "Pancreatic Cancer" (4 trials), "ALS" (3 trials), "Breast Cancer" (3 trials) and "Ulcerative Colitis" (3 trials). Many other conditions were trialed in "Fukushima Medical University Hospital" in a lesser frequency.

Most popular intervention types in "Fukushima Medical University Hospital" are "Drug" (77 trials), "Biological" (12 trials), "Other" (10 trials), "Procedure" (8 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (23 trials), "Cyclophosphamide" (5 trials), "Paclitaxel" (5 trials), "MT-1186" (4 trials) and "Sham Procedure" (4 trials). Other intervention names were less common.

The vast majority of trials in "Fukushima Medical University Hospital" are 87 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Fukushima Medical University Hospital". undefined are not yet recruiting, 15 are recruiting, 21 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 41 completed trials in Fukushima Medical University Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Fukushima Medical University Hospital, 12 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 57 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".